≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of cervix uteri, endocervix

DOID EFO Endpoint Browser

CD2_INSITU_CERVIX_UTERI_ENDOCERVIX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D06.0&
  • Cause of death: ICD-10 — D06.0&

2 out of 7 registries used, show all original rules.

438

4. Check minimum number of events

None

438

5. Include endpoints

None

438

6. Filter based on genotype QC (FinnGen only)

438

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D06
Name in latin
Carcinoma in situ endocervicis (uteri)

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 438 438 -
Unadjusted period prevalence (%) 0.15 0.15 -
Median age at first event (years) 38.86 38.86 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
381
Matched controls
3810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
+∞
323.0
381
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
63.7
225.5
273
145
ULA02
NOMESCO Finland
Kolposcopy
34.8
189.0
299
361
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
33.6
186.2
302
388
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
1915.2
140.9
128
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
16.9
129.9
269
474
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
19.2
124.1
215
240
LDA10
NOMESCO Finland
Curettage of cervix uteri
21.2
102.3
161
127
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
24.2
85.8
126
76
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
459.4
77.8
75
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
25.3
69.2
99
52
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
191.5
63.1
64
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
132.1
34.3
36
*
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
326.9
30.2
30
*
8140/2-C53.0
ICD-O-3
Adenocarcinoma in situ, NOS, of endocervix
+∞
27.4
26
*
8140/2-C53.1
ICD-O-3
Adenocarcinoma in situ, NOS, of exocervix
+∞
26.4
25
*
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
7.5
25.5
63
98
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
255.3
23.9
24
*
N87.1
ICD-10 Finland
Moderate cervical dysplasia
8.5
23.6
53
71
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
7.5
22.5
55
84
LEB00
NOMESCO Finland
Biopsy of vagina
11.3
21.2
40
39
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
9.2
20.8
44
53
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.6
17.7
217
1287
ZXC00
NOMESCO Finland
Use of diathermy
22.2
17.5
25
12
LCD10
NOMESCO Finland
Vaginal hysterectomy
7.7
17.4
41
59
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
31.6
16.3
21
7
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
47.0
15.2
18
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
83.4
14.7
16
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
155.7
14.6
15
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.8
13.9
101
431
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
13.6
13
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.7
12.5
99
442
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.8
12.1
40
90
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
13.1
11.8
20
16
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
31.1
11.7
15
5
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
123.6
11.5
12
*
C539, 6666, 0
ICD-O-3
NA
9.3
11.4
23
26
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.4
11.2
41
102
N87.0
ICD-10 Finland
Mild cervical dysplasia
5.0
11.1
35
75
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
33.5
10.4
13
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
7.0
10.1
24
36
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.0
9.9
18
17
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
56.5
9.7
11
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
102.5
9.5
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
11.1
8.9
16
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.9
8.5
34
93
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
92.0
8.4
9
*
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
8.4
8
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
34.1
8.1
10
*
WX402
NOMESCO Finland
General anaesthesia
2.2
8.1
86
439
G01AA10
ATC
clindamycin; vaginal
2.1
7.9
107
605
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
81.6
7.4
8
*
B01AB05
ATC
enoxaparin; parenteral
1.9
6.8
105
622
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.7
6.6
21
47
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
6.5
32
105
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
8.4
6.4
13
16
B01AB10
ATC
tinzaparin; parenteral
3.1
6.3
32
108
8010/2-C53.9
ICD-O-3
Carcinoma in situ, NOS, of cervix uteri
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
85
127
8.06
56.46
3.1
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
108
268
5.02
41.98
2.7
1.5
—
—
—
0
0
(4035726)
96
257
4.50
33.48
1.4
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
237
1260
2.92
26.81
2.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
261
1647
2.45
18.33
2.9
2.0
—
—
—
0
0
(4281824)
26
36
7.61
17.99
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
24
35
7.20
15.85
2.8
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
66
313
2.31
8.12
1.8
2.4
u/ml
21.4
36.9
1.07
61
303
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
232
1775
1.65
6.21
3.7
3.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
24
5.11
5.77
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
232
1828
1.57
5.13
4.3
4.2
estimate
0.0
0.0
0.50
63
365
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
272
2.03
4.99
2.1
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
58
317
1.96
4.92
3.4
3.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
233
1849
1.56
4.91
3.2
3.0
estimate
0.0
0.0
0.50
62
352
(3044640) Blood type and Crossmatch panel - Blood
153
1119
1.56
4.56
1.8
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
166
1249
1.53
4.30
3.5
4.2
g/l
36.8
36.9
0.11
153
1169
(3041096) Erythrocytes [Presence] in Urine by Automated
144
1090
1.48
3.49
3.2
2.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
200
1613
1.44
3.48
7.9
7.6
e9/l
0.0
0.0
0.39
172
1341
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
180
1430
1.44
3.37
3.2
3.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
390
3641
1.65
2.75
9.6
9.9
mmol/l
3.9
3.9
0.33
380
3534
(3035350) Ketones [Presence] in Urine by Test strip
216
1822
1.37
2.66
3.1
3.0
estimate
0.0
0.0
0.50
62
360
(3019550) Sodium [Moles/volume] in Serum or Plasma
388
3632
1.60
2.53
9.6
9.8
mmol/l
139.6
139.6
0.04
379
3536
(3002256) Pathology report gross observation
68
473
1.52
2.44
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
106
810
1.41
2.34
2.5
2.4
e6/l
0.3
0.3
0.26
82
586
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
371
3454
1.48
2.32
9.0
8.4
ml/min/173m2
91.5
91.6
0.05
314
2785
(3002582) Erythrocytes [#/volume] in Urine
115
893
1.39
2.31
2.5
2.6
e6/l
167.9
64.8
0.33
88
656
(3004588) Protein electrophoresis panel - Serum or Plasma
25
135
1.90
2.27
1.2
1.9
—
—
—
0
0
(3015736) pH of Urine
169
1414
1.32
2.06
2.7
2.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
131
1057
1.34
2.05
2.7
2.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
105
820
1.37
2.03
1.8
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
35
219
1.65
1.98
3.1
3.2
mmol/l
1.2
1.2
0.48
28
190
(3007461) Platelets [#/volume] in Blood
433
4238
2.90
1.91
15.7
15.3
e9/l
269.5
268.1
0.18
426
4167
(3029937) Albumin [Presence] in Urine by Test strip
118
947
1.34
1.90
3.3
3.3
estimate
0.0
0.0
0.80
63
362
(3013290) Carbon dioxide [Partial pressure] in Blood
12
52
2.34
1.89
4.3
1.9
kpa
5.1
5.0
0.22
12
52
(3027315) Oxygen [Partial pressure] in Blood
12
52
2.34
1.89
4.3
1.9
kpa
9.4
9.5
0.07
12
52
(3012501) Base excess in Blood by calculation
12
52
2.34
1.89
4.3
1.9
mmol/l
2.7
2.6
—
7
39
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
63
458
1.44
1.84
2.2
2.2
e6/l
1.4
1.1
0.41
40
237
(3013826) Glucose [Moles/volume] in Serum or Plasma
208
1818
1.27
1.75
3.4
4.0
mmol/l
6.4
6.3
0.27
199
1636
(3035285) Chloride [Moles/volume] in Venous blood
7
24
2.95
1.73
2.6
2.4
mmol/l
106.4
106.2
—
7
24
(3041354) Potassium [Moles/volume] in Venous blood
7
24
2.95
1.73
2.6
2.4
mmol/l
3.9
4.0
—
7
24
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
24
2.95
1.73
2.6
2.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
193
1678
1.27
1.67
6.0
5.4
%
0.7
0.7
0.15
188
1559
(3013512) EKG study
93
742
1.32
1.55
2.6
2.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
394
3771
1.45
1.53
9.9
10.1
mg/l
21.6
18.0
1.36
314
2860
(3037467) Urinalysis macro (dipstick) panel - Urine
282
2580
1.26
1.53
3.8
3.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
58
2.10
1.50
3.3
3.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
210
1868
1.24
1.43
5.7
5.4
e9/l
0.0
0.0
0.64
191
1657
(3001604) Monocytes [#/volume] in Blood
209
1859
1.24
1.42
5.7
5.4
e9/l
0.5
0.5
0.35
191
1654
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
409
3951
1.53
1.42
8.8
8.5
u/l
23.5
23.7
0.08
397
3856
(3001019) Free T4 and TSH panel - Serum or Plasma
30
438
0.66
1.38
1.7
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
23
2.63
1.37
1.0
1.1
miu/ml
1308.0
1661.9
—
6
23
(3026782) Osmolality of Urine
74
582
1.33
1.37
2.7
2.2
mosm/kgh2o
548.1
534.6
0.21
64
492
(3003694) ABO and Rh group [Type] in Blood
147
1263
1.25
1.36
1.6
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
136
1161
1.25
1.33
2.8
3.0
e6/l
198.2
54.6
0.82
98
729
(36304419) Bacteria [Presence] in Urine
100
823
1.28
1.33
2.5
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
43
2.12
1.31
1.8
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
135
1154
1.25
1.30
5.7
5.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
196
1746
1.22
1.28
6.1
5.3
%
2.7
2.6
0.14
191
1625
(3019060) Gas panel - Arterial blood
19
115
1.68
1.27
2.8
9.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
19
296
0.63
1.19
1.2
1.6
mu/l
203.4
319.0
3.02
14
266
(3019069) Monocytes/100 leukocytes in Blood
196
1755
1.21
1.19
6.3
5.5
%
8.2
7.8
0.82
191
1648
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
126
1.62
1.16
3.9
4.7
mmol/l
24.5
24.7
0.08
20
126
(3023368) Bacteria identified in Blood by Culture
77
624
1.28
1.16
3.1
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
35
0.00
1.15
0.0
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
114
971
1.24
1.13
4.1
5.0
inr
1.0
1.1
3.15
45
342
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
438
1.32
1.10
2.3
2.3
e6/l
5.3
4.5
0.15
33
216
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
32
2.21
1.08
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
147
0.54
1.05
1.9
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
214
1949
1.19
1.05
5.7
5.7
e9/l
0.2
0.2
0.64
194
1760
(36660697) Celiac disease serology panel - Serum
27
377
0.70
1.02
1.1
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
53
1.91
1.02
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
140
1.53
0.99
4.3
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
75
620
1.25
0.97
2.2
2.2
e6/l
8.6
9.8
0.23
66
538
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
36
1.96
0.97
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
123
1072
1.20
0.97
3.2
3.0
mmol/l
2.3
2.3
1.03
115
974
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
74
886
0.80
0.96
1.6
1.6
mmol/l
1.3
1.4
0.27
62
774
(3002030) Lymphocytes/100 leukocytes in Blood
200
1822
1.18
0.95
6.1
5.3
%
29.3
29.6
0.16
193
1702
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
17
109
1.58
0.95
10.4
7.2
mmol/l
23.9
23.9
0.01
17
104
(3003396) Base excess in Arterial blood by calculation
32
235
1.39
0.95
7.2
8.6
mmol/l
-0.0
1.0
0.70
25
178
(3018010) Neutrophils/100 leukocytes in Blood
198
1804
1.18
0.94
6.0
5.1
%
55.5
56.7
0.89
193
1693
(3019198) Lymphocytes [#/volume] in Blood
210
1925
1.17
0.92
5.8
5.4
e9/l
1.9
2.0
0.44
194
1748
(3023323) Follitropin [Units/volume] in Serum or Plasma
59
478
1.27
0.91
1.3
1.3
iu/l
31.8
26.3
0.52
50
418
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
334
0.70
0.91
1.7
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
297
0.69
0.87
1.3
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
585
0.78
0.86
1.6
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
164
1481
1.17
0.85
5.4
5.6
mmol/l
1.2
1.2
0.21
128
1258
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
80
1.64
0.85
3.5
2.5
mg/l
1.4
1.4
0.08
13
72
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
446
1.27
0.85
1.5
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
166
0.59
0.85
1.7
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
113
1.52
0.83
10.3
12.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
32
1.89
0.82
2.2
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.81
2.4
2.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
315
0.72
0.81
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
314
0.72
0.79
1.6
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
309
3231
0.85
0.79
4.2
4.6
pmol/l
14.2
14.3
0.36
285
3053
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
60
497
1.24
0.78
2.3
2.3
mmol/l
2.4
2.4
0.12
53
439
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
313
0.72
0.78
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
313
0.72
0.78
1.6
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
27
0.00
0.77
0.0
2.9
—
51.3
—
0
16
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
94
1074
0.84
0.76
1.3
1.2
u/ml
0.5
2.0
1.96
33
305
(3009542) Hematocrit [Volume Fraction] of Blood
378
3667
1.22
0.74
10.9
10.9
%
39.0
39.6
0.79
313
3062
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
25
2.01
0.73
8.2
9.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
76
1.60
0.72
2.5
3.5
e9/l
3.3
4.3
1.31
12
76
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
76
1.60
0.72
2.5
3.8
%
53.4
57.2
0.57
12
76
(3002179) Metamyelocytes/100 leukocytes in Blood
32
248
1.31
0.71
5.1
3.7
%
0.4
0.8
—
5
46
(3019225) pH of Specimen
35
275
1.30
0.71
3.6
3.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
1.0
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
312
3248
0.86
0.69
3.7
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
918
0.84
0.69
6.4
6.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
143
1303
1.14
0.64
4.9
4.9
mmol/l
1.2
1.2
0.22
124
1196
(3022806) Fractional oxyhemoglobin in Capillary blood
5
29
1.73
0.64
1.0
1.6
%
91.9
91.6
—
5
29
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
69
594
1.19
0.64
1.7
1.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
104
1.46
0.63
3.9
2.6
mg/l
7.7
9.6
0.67
15
95
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
131
1189
1.15
0.62
1.6
1.8
pmol/l
94.2
99.4
0.49
68
659
(3009508) Creatinine [Moles/volume] in Urine
71
815
0.85
0.62
3.4
2.9
mmol/l
8.1
7.7
0.35
60
699
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(4010399)
26
201
1.31
0.60
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
80
1.51
0.60
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
157
1.35
0.60
2.6
1.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
22
0.00
0.59
0.0
2.5
—
9.3
—
0
14
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
264
0.75
0.59
1.7
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1595
1.13
0.59
2.0
2.3
nmol/l
74.4
75.1
0.14
157
1492
(3018418) pH of Serum or Plasma
98
875
1.15
0.59
3.3
3.3
ph
7.4
7.4
0.08
26
162
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
3.5
—
—
—
0
0
(4027681)
6
35
1.72
0.58
1.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
149
0.66
0.57
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
339
1.23
0.57
4.4
4.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
24
185
1.31
0.57
2.0
2.9
mmol/l
1.6
2.0
0.25
17
145
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
86
0.58
0.56
1.8
2.0
%
12.5
13.3
—
5
86
(3005033) Fetal Nuchal fold Thickness US
20
262
0.75
0.56
1.7
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
94
840
1.15
0.56
1.9
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
38
1.59
0.54
1.5
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
24
187
1.30
0.54
2.0
2.9
kpa
5.8
5.8
0.10
24
182
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
74
1.50
0.54
1.1
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
270
0.77
0.53
1.7
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
72
636
1.16
0.51
1.4
1.4
titre
473.7
513.5
0.05
19
135
(3023511) Choriogonadotropin [Units/volume] in Urine
17
223
0.75
0.49
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
341
3503
0.88
0.49
3.3
3.5
mmol/l
5.6
5.6
0.15
320
3298
(3008898) HLA-B27 [Presence]
18
234
0.76
0.49
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
103
935
1.13
0.49
2.0
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
109
0.64
0.49
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
109
0.64
0.49
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
24
190
1.28
0.49
2.0
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
277
0.78
0.48
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
117
1272
0.89
0.48
3.1
2.9
u/l
27.7
27.6
0.01
108
1223
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
191
1.27
0.47
1.5
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
85
1.42
0.47
1.0
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
221
0.76
0.47
1.5
1.3
miu/ml
206.1
231.6
—
9
111
(3025159) Blasts/100 leukocytes in Blood
30
246
1.24
0.47
6.1
4.0
%
0.0
0.1
—
5
51
(1616796) Gas panel - Central venous blood
7
49
1.44
0.46
5.9
1.8
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
50
1.41
0.45
1.6
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
130
1.32
0.44
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
273
0.80
0.44
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
43
370
1.18
0.43
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
357
3487
1.13
0.42
3.0
3.2
mmol/l
1.2
1.2
0.41
335
3305
(3017181) Myelocytes/100 leukocytes in Blood
32
268
1.21
0.42
5.9
3.9
%
0.4
1.0
—
5
65
(40760892) CBC W Ordered Manual Differential panel - Blood
107
985
1.11
0.41
4.4
3.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
33
1.52
0.41
1.2
3.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
1.2
—
0
15
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
3.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
343
3345
1.12
0.41
12.1
12.3
%
13.3
13.5
2.38
335
3292
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
17
0.00
0.40
0.0
1.8
—
10.4
—
0
17
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
388
0.84
0.40
1.3
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
221
2112
1.09
0.40
8.7
8.1
e9/l
3.7
3.9
0.83
205
1862
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
88
804
1.12
0.39
1.4
1.3
iu/ml
24.8
25.7
0.04
34
279
(3044889) 12 lead EKG panel
236
2264
1.09
0.39
2.7
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
95
1031
0.90
0.38
1.5
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
136
0.73
0.38
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
167
1579
1.09
0.38
2.3
2.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
246
0.80
0.38
1.6
1.8
mg/l
3.0
2.8
0.06
14
162
(3014007) Fractional oxyhemoglobin in Arterial blood
15
116
1.30
0.37
12.9
8.0
%
94.1
94.7
0.21
15
116
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
69
1.31
0.37
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
61
678
0.88
0.37
3.8
3.2
mg/l
29.7
322.2
1.11
39
424
(3021440) Promyelocytes/100 leukocytes in Blood
30
254
1.19
0.36
6.2
4.0
%
0.0
0.1
—
5
60
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
90
1.34
0.36
1.0
1.3
—
1.6
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
79
0.63
0.36
1.4
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
1.0
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
84
913
0.90
0.35
1.3
1.4
g/l
2.2
2.1
0.16
60
582
(3018677) aPTT in Platelet poor plasma by Coagulation assay
33
382
0.85
0.35
2.3
1.8
s
30.0
29.3
0.39
33
376
(3013707) Erythrocyte sedimentation rate by Westergren method
281
2726
1.09
0.34
4.0
3.8
mm/h
10.1
9.2
0.46
264
2569
(1617658) Protocol used for examination of sentinel lymph nodes
6
45
1.34
0.34
1.3
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
88
0.68
0.33
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
76
827
0.90
0.33
1.5
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
23
192
1.21
0.32
1.1
1.3
—
0.9
—
0
13
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
651
0.89
0.32
1.3
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
47
1.28
0.32
1.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
83
1.33
0.32
1.0
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
92
1.31
0.32
1.9
2.2
%
1.5
1.2
0.28
12
92
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
362
1.15
0.31
2.6
3.3
%
29.5
32.5
1.07
29
265
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
142
0.77
0.31
1.4
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
287
1.16
0.31
1.8
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
36
409
0.87
0.31
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
1227
1.08
0.31
1.7
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
71
772
0.90
0.30
2.7
3.1
kg/l
1.0
1.0
—
9
105
(3001122) Ferritin [Mass/volume] in Serum or Plasma
205
2128
0.93
0.29
2.9
2.9
ug/l
73.8
62.9
0.85
194
2030
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
57
1.23
0.29
1.0
1.4
—
30.1
—
0
5
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
49
542
0.89
0.29
1.5
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
62
1.30
0.28
6.1
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
50
454
1.11
0.26
1.7
1.6
nmol/l
1217.0
1141.2
0.20
35
358
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
20
169
1.19
0.26
3.6
2.2
u/l
41.4
38.4
0.32
20
154
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
72
0.69
0.26
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
108
1143
0.93
0.26
1.5
1.6
—
—
—
0
0
(4094501)
5
74
0.67
0.26
1.2
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
74
0.67
0.26
1.4
1.9
ug/l
0.1
5.3
—
5
67
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
72
1.26
0.26
1.1
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
72
774
0.92
0.25
2.0
2.1
umol/l
292.6
4494.5
2.78
62
698
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
609
0.91
0.25
1.8
2.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
29
255
1.15
0.25
8.1
5.4
mmol/l
103.7
104.7
0.46
29
249
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
137
0.80
0.24
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
32
359
0.88
0.24
1.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
66
710
0.92
0.24
4.7
3.9
mg/mmol
4.5
8.1
0.89
43
435
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
38
1.32
0.23
2.0
3.6
mu/l
18.1
24.6
—
5
38
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
636
0.92
0.22
1.6
1.6
pmol/l
440.1
36204301.2
1.05
47
569
(3005719) IgG [Mass/volume] in Serum or Plasma
31
277
1.13
0.22
2.4
2.6
g/l
10.5
10.2
0.18
31
258
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
356
0.89
0.21
1.5
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
1.5
—
1.2
—
0
10
(3001556) Androgen free Index in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.7
—
60.5
—
0
10
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
1292.2
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
6.0
—
0
12
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
12
0.00
0.21
0.0
2.3
—
1.2
—
0
12
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
8
105
0.76
0.21
1.3
1.2
—
108.3
—
0
12
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
879
0.93
0.21
1.7
1.7
mg/l
0.7
0.7
0.01
62
658
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
11
134
0.82
0.21
1.6
3.1
mmol/l
1.7
1.3
0.15
11
95
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
43
468
0.91
0.20
1.3
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
49
1.23
0.20
1.7
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
218
0.87
0.20
1.4
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
50
1.20
0.20
1.0
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
487
0.92
0.19
1.9
3.0
ng/l
34.4
374.8
1.22
19
264
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
49
528
0.92
0.19
1.4
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
82
865
0.94
0.19
1.9
2.0
mg/l
2.5
2.7
0.57
64
754
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
361
3652
0.93
0.18
4.8
5.2
mu/l
1.7
2.0
0.52
332
3484
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
185
0.86
0.18
1.8
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
132
0.83
0.18
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
185
1.14
0.18
1.2
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
166
1.15
0.18
10.3
6.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
434
0.91
0.18
1.3
1.2
iu/ml
167.2
172.9
—
8
187
(3007853) Bacteria identified in Skin by Aerobe culture
40
369
1.09
0.17
1.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
215
1.12
0.17
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
8
68
1.18
0.16
1.9
1.9
ug/l
117.1
158.6
—
8
57
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
92
1.20
0.16
1.1
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
405
4021
1.10
0.16
10.0
9.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
111
1.18
0.16
1.5
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
268
2633
1.05
0.16
7.1
6.3
u/l
69.5
72.9
1.01
255
2480
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
76
0.79
0.15
1.3
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
119
0.84
0.15
1.6
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
84
803
1.06
0.15
1.2
1.3
u/ml
9.1
13.7
0.25
36
341
(3000764) Benzodiazepines [Presence] in Urine
25
227
1.11
0.14
1.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
227
1.11
0.14
1.6
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
874
1.05
0.14
1.7
2.0
u/l
106.1
121.1
0.53
84
834
(21494755) Public health laboratory ask at order entry panel
62
589
1.06
0.13
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
228
1.10
0.13
1.6
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
248
1.09
0.13
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
293
0.92
0.13
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
251
0.91
0.12
2.1
2.2
ml/min/173m2
80.0
78.6
—
8
96
(42529406) Shigella sp [Presence] in Stool by Culture
11
126
0.87
0.11
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
316
3190
0.97
0.10
4.1
4.3
mmol/mol
37.5
37.7
0.24
299
3024
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
1.2
1.2
nmol/l
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
145
0.89
0.09
1.2
1.1
—
4.3
—
0
27
(3027944) Amphetamines [Presence] in Urine
24
223
1.08
0.09
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
124
0.88
0.09
1.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.2
1.4
nmol/l
25.9
30.1
—
6
45
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
257
0.93
0.08
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
9.4
6.6
umol/l
323.9
375.1
—
7
57
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
77
1.04
0.07
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
80
0.87
0.07
3.3
2.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
128
1.10
0.06
1.1
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
8
95
0.84
0.06
2.5
2.2
g/l
3.8
3.7
—
8
90
(3021960) Folate [Moles/volume] in Serum or Plasma
69
671
1.03
0.06
1.4
1.4
nmol/l
18.6
21.7
1.20
59
591
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
41
394
1.04
0.06
2.8
2.2
%
27.4
23.7
0.85
36
336
(4034850)
9
105
0.85
0.06
6.8
6.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
171
1687
1.02
0.06
5.6
5.0
umol/l
8.7
9.5
0.89
166
1592
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
523
1.04
0.06
1.8
1.6
%
1.4
1.3
0.32
46
478
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
111
0.90
0.06
1.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
272
2698
1.02
0.06
2.8
2.8
u/l
33.3
34.2
0.10
264
2583
(3026008) Bacteria identified in Urine by Culture
99
1008
0.98
0.05
2.7
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
181
0.94
0.05
1.5
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
387
1.04
0.04
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
54
527
1.03
0.04
2.2
2.7
ng/l
639.0
783.8
0.15
43
432
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
109
0.92
0.04
1.1
1.2
—
35.8
—
0
8
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
190
0.95
0.04
1.6
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
169
0.94
0.03
2.4
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
103
1017
1.02
0.03
2.4
2.6
ng/l
22.0
18.5
0.19
37
456
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
362
3632
0.98
0.03
3.2
3.5
mmol/l
1.6
1.6
0.12
340
3454
(3014111) Lactate [Moles/volume] in Serum or Plasma
19
199
0.95
0.03
10.3
5.2
mmol/l
1.2
1.2
0.00
19
191
(3011397) Hemoglobin [Presence] in Urine by Test strip
80
790
1.02
0.02
2.8
3.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
123
1.06
0.01
1.0
1.2
—
2.9
—
0
16
(3042936) Bacteria identified in Isolate by Culture
40
392
1.02
0.01
1.5
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
233
1.03
0.01
3.2
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
31
317
0.98
0.01
4.2
4.9
mmol/l
1.0
1.0
0.92
31
295
(3048689) Calprotectin [Mass/mass] in Stool
58
573
1.01
0.01
2.4
2.4
ug/g
124.6
80.7
0.81
42
447
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
102
1013
1.01
0.01
2.3
2.2
u/l
48.8
55.5
2.16
96
939
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
116
0.95
0.00
1.1
1.1
u/ml
0.3
1.4
—
5
46
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
386
0.98
0.00
1.6
2.2
umol/l
3.7
5.1
2.11
26
334
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
124
0.97
0.00
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
22
224
0.98
0.00
2.9
3.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
123
0.97
0.00
1.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
163
0.98
0.00
1.7
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
257
1.01
0.00
1.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
26
263
0.99
0.00
1.3
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
13
132
0.98
0.00
1.1
1.3
ug/l
2.2
2.5
0.26
13
118
(3008401) Mugwort IgE Ab [Units/volume] in Serum
10
101
0.99
0.00
1.0
1.0
u/ml
0.0
1.3
—
5
42
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
119
1.01
0.00
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
139
1.01
0.00
2.4
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
149
1.01
0.00
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
21
211
1.00
0.00
1.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
38
381
1.00
0.00
2.0
2.0
u/l
1432.3
5239.8
1.26
15
156
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
365
3646
1.01
0.00
3.3
3.6
mmol/l
4.9
4.9
0.76
346
3480
(3022145) Colonoscopy Study observation
40
396
1.01
0.00
1.3
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
7
70
1.00
0.00
4.7
4.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
78
0.90
0.00
1.4
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
80
1.00
0.00
1.4
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.5
—
0
6
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
68
0.88
0.00
1.7
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
51
0.98
0.00
1.4
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
23
230
1.00
0.00
6.7
12.0
inr
1.5
1.2
—
7
36
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
10.6
—
26.8
—
0
7
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
25
250
1.00
0.00
4.9
3.4
u/l
207.5
233.1
0.89
25
242
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.8
—
363.6
—
0
5
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
87
0.92
0.00
1.4
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
63
0.95
0.00
1.3
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
94
0.96
0.00
1.1
3.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
368
3680
1.00
0.00
3.4
3.8
mmol/l
3.0
2.9
0.83
345
3494
(3000475) Leukocytes [#/volume] in Synovial fluid
5
59
0.85
0.00
3.0
1.8
e6/l
583.6
12665.7
—
5
46
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
81
0.99
0.00
3.0
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_CERVIX_UTERI_ENDOCERVIX – Carcinoma in situ of cervix uteri, endocervix

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).